Close



Apr 1, 2024 04:02PM
Mar 27, 2024 08:30AM
Feb 20, 2024 09:00AM
Feb 1, 2024 09:11AM
Nov 9, 2023 04:02PM
Nov 6, 2023 08:00AM
Nov 3, 2023 09:05AM Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thromboti
Nov 2, 2023 09:05AM
Oct 19, 2023 08:31AM
Oct 19, 2023 08:30AM
Oct 16, 2023 07:32AM
Oct 16, 2023 07:30AM
Aug 9, 2023 08:00AM
Aug 4, 2023 08:00AM Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023
Jun 21, 2023 08:30AM
Jun 12, 2023 08:45AM
Jun 1, 2023 11:01AM
Jun 1, 2023 11:00AM
May 9, 2023 04:02PM
May 4, 2023 04:06PM
Apr 25, 2023 09:25AM Omeros (OMER) Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria
Apr 25, 2023 09:25AM
Apr 10, 2023 08:45AM
Apr 10, 2023 08:45AM
Mar 13, 2023 04:02PM
Mar 10, 2023 03:37PM
Mar 10, 2023 03:37PM
Mar 7, 2023 09:00AM Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023
Feb 6, 2023 08:51AM
Feb 6, 2023 08:50AM
Nov 9, 2022 04:02PM
Nov 8, 2022 08:36AM
Nov 8, 2022 08:30AM
Nov 4, 2022 09:00AM
Nov 3, 2022 09:00AM Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
Oct 3, 2022 07:11AM
Oct 3, 2022 07:10AM
Sep 15, 2022 09:06AM
Sep 15, 2022 09:06AM
Sep 15, 2022 09:02AM
Aug 17, 2022 08:40AM
Aug 17, 2022 08:40AM Omeros Corporation Receives Interim Response from FDA on Formal Dispute Resolution Request for Narsoplimab
Aug 9, 2022 04:02PM
Aug 4, 2022 08:30AM
Jul 29, 2022 08:45AM
Jul 29, 2022 08:45AM
Jun 15, 2022 08:00AM
May 18, 2022 07:43AM
May 10, 2022 04:02PM Omeros Corporation Reports First Quarter 2022 Financial Results
May 4, 2022 08:30AM

251,770 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All